Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
NCT00682786Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2002
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, irinotecan in Rectal cancer (RC), sponsored by Washington University School of Medicine. Started Oct 2002; status: completed.
02
Drugs
fluorouracilirinotecan
03
Conditions
Rectal cancer (RC)
Beyond the preview
Go deeper on NCT00682786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682786.